Dr. Robin Simon Berrin, D.M.D. Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 1209 Bonita St, Grants, NM 87020 Phone: 505-876-4034 |
Dr. Ken Abraham, DDS Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 901 E Roosevelt Ave, Grants, NM 87020 Phone: 505-285-4444 Fax: 505-285-6207 |
Dr. Marcellus Gladney, D.M.D. Dentist - Pediatric Dentistry Medicare: Not Enrolled in Medicare Practice Location: 1209 Bonita St, Grants, NM 87020 Phone: 505-876-4034 Fax: 505-876-4036 |
Kristin Kay Murphy Dentist - Pediatric Dentistry Medicare: Not Enrolled in Medicare Practice Location: 805 East Street, Grants, NM 87020 Phone: 505-285-3443 |
Dr. Patricia B Valdivia, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1209 Bonita St, Grants, NM 87020 Phone: 505-876-4034 Fax: 505-876-4036 |
Dr. Jeffrey Ray Mattila, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 200 Lincoln Ave, Grants, NM 87020 Phone: 505-287-2000 |
News Archive
The experimental drug selumetinib is the first targeted therapy to demonstrate significant clinical benefit for patients with metastatic uveal melanoma, according to new Memorial Sloan-Kettering Cancer Center research presented on Saturday, June 1, at the 49th annual meeting of the American Society of Clinical Oncology.
Northwestern Medicine scientists are continuing to unravel the molecular changes that underlie one of the world's deadliest and most infamous respiratory infections.
Teva Pharmaceutical Industries Ltd. and Alcobra Ltd. announced today top-line results from a six week, randomized, placebo-controlled, Phase II multi-center study designed to assess the safety and efficacy of MG01CI in adults with attention deficit hyperactivity disorder (ADHD).
Plastic surgeons and other cosmetic professionals are familiar with the challenges posed by patients with body dysmorphic disorder (BDD) seeking cosmetic procedures, reports a survey study in the February issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons.
A clinical trial of a drug that researchers hope can prevent or delay the onset of epilepsy in children with tuberous sclerosis has begun at McGovern Medical School at The University of Texas Health Science Center at Houston.
› Verified 4 days ago